L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.
until further notice
SourceNeuropsychopharmacology (New York), 32, 1, (2007), pp. 180-189
Article / Letter to editor
Display more detailsDisplay less details
Neuropsychopharmacology (New York)
SubjectDCN 1: Perception and Action; UMCN 3.2: Cognitive neurosciences
Evidence indicates that dopaminergic medication in Parkinson's disease may impair certain aspects of cognitive function, such as reversal learning. We used functional magnetic resonance imaging in patients with mild Parkinson's disease to investigate the neural site at which L-DOPA acts during reversal learning. Patients were scanned both ON and OFF their normal dopamine-enhancing L-DOPA medication during the performance of a probabilistic reversal learning task. We demonstrate that L-DOPA modulated reversal-related activity in the nucleus accumbens, but not in the dorsal striatum or the prefrontal cortex. These data concur with evidence from studies with experimental animals and indicate an important role for the human nucleus accumbens in the dopaminergic modulation of reversal learning.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.